Ifosfamide and irinotecan in solid tumors:: A phase I dose-finding trial

被引：0
作者：
Moyano, AJ
Seguí, MA
Abad, T
Urruticoechea, L
López, JLG
Nogué, M
Dominguez, MS
Balcells, M
Dorado, JF
机构：
[1] Hosp Ramon y Cajal, Med Oncol Serv, E-28034 Madrid, Spain
[2] Hosp Parc Tauli, Med Oncol Serv, Sabadell, Spain
[3] Hosp Txagorvitxu, Med Oncol Serv, Vitoria, Spain
[4] Prasfarma & Co, Barcelona, Spain
[5] Cibest, Madrid, Spain
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 7
页数：5
相关论文
共 50 条
  • [41] Phase I dose-finding study of weekly (W) docetaxel (T) followed by flavopiridol (F) for patients with metastatic solid tumors
    Fornier, Monica N.
    Rathkopi, Dana
    Shah, Manish
    Hudis, Clifford
    O'Reilly, Eileen
    Kormansky, Jeremy
    Winkelmann, Jennifer
    Kelsen, David
    Norton, Larry
    Schwartz, Gary K.
    ANNALS OF ONCOLOGY, 2004, 15 : 103 - 103
  • [42] A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors
    Fakih, MG
    Pendyala, L
    Smith, PF
    Creaven, PJ
    Reid, ME
    Badmaev, V
    Azrak, RG
    Prey, JD
    Lawrence, D
    Rustum, YM
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1237 - 1244
  • [43] A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors
    Fakih, Marwan G.
    Pendyala, Lakshmi
    Brady, William
    Smith, Patrick F.
    Ross, Mary E.
    Creaven, Patrick J.
    Badmaev, Vladimir
    Prey, Joshua D.
    Rustum, Youcef M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 499 - 508
  • [44] Phase I Dose Escalation Study of Gemcitabine plus Irinotecan in Advanced Solid Tumors
    Dugan, Elizabeth
    Truax, Roxanne
    Meadows, Kellen L.
    Blobe, Gerald C.
    Morse, Michael A.
    Fernando, Nishan H.
    Gockerman, Jon P.
    Petros, William P.
    Hurwitz, Herbert I.
    ANTICANCER RESEARCH, 2009, 29 (12) : 5149 - 5153
  • [45] Phase I dose-finding and pharmacologic study of cisplatin (P), irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors
    Enzinger, Peter C.
    Earle, Craig
    Zhu, Andrew
    Blaskowsky, Lawrence
    Kulke, Matthew
    Ryan, David
    Langford, Lauren
    Michelini, Ann
    Meyerhardt, Jeffrey
    ANNALS OF ONCOLOGY, 2004, 15 : 106 - 106
  • [46] A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors
    Marwan G. Fakih
    Lakshmi Pendyala
    William Brady
    Patrick F. Smith
    Mary E. Ross
    Patrick J. Creaven
    Vladimir Badmaev
    Joshua D. Prey
    Youcef M. Rustum
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 499 - 508
  • [47] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Pierre Fumoleau
    Jose Manuel Trigo
    Nicolas Isambert
    Dorothée Sémiond
    Sunil Gupta
    Mario Campone
    BMC Cancer, 13
  • [48] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Fumoleau, Pierre
    Trigo, Jose Manuel
    Isambert, Nicolas
    Semiond, Dorothee
    Gupta, Sunil
    Campone, Mario
    BMC CANCER, 2013, 13
  • [49] Safety and dose-finding trial of tadalafil administered for fetus in labor: A phase I clinical study
    Tamaishi, Yuya
    Tanaka, Hiroaki
    Hirai, Toshinori
    Hiramatsu, Shun-ichi
    Takakura, Sho
    Magawa, Shoichi
    Tanaka, Kayo
    Kondo, Eiji
    Iwamoto, Takuya
    Ikeda, Tomoaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2024, 50 (03) : 448 - 455
  • [50] A Phase 1 Trial of Olaratumab as Monotherapy and in Combination with Doxorubicin, Vincristine/Irinotecan, or High-Dose Ifosfamide in Pediatric Patients with Relapsed/Refractory Solid Tumors
    Mascarenhas, L.
    Ogawa, C.
    Laetsch, T.
    Weigel, B.
    Bishop, M.
    Krystal, J.
    Levy, D.
    Mo, G.
    Wright, J.
    Dubois, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S433 - S434
12345